• For Individuals
  • For Institutions
  • Download
  • Help

  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文（廣東話）Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials

Event Tracking

Nov20
Recursion Pharmaceuticals Inc Executives Sell Stocks
00:42
Nov6
Recursion Pharmaceuticals Inc. CEO Reports Common Stock Disposition
21:27
Nov5
Recursion Pharmaceuticals released FY2025 Q3 earnings on November 5 Pre-Market EST, actual revenue USD 5.175 M (forecast USD 19.36 M), actual EPS USD -0.3629 (forecast USD -0.3625)
14:30
Recursion Pharmaceuticals released FY2025 9 Months earnings on November 5 Pre-Market (EST), actual revenue USD 39.14 M, actual EPS USD -1.2775
14:30
Recursion Pharmaceuticals Leadership Transition: Najat Khan to Replace Chris Gibson as CEO
11:39
Recursion Pharmaceuticals reports Q3 2025 net loss of $162.3 million
11:30

Schedules & Filings

Schedules
Filings
Nov5
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 5.175 M, Net Income -162.25 M, EPS -0.3629

Aug5
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 19.22 M, Net Income -171.9 M, EPS -0.4118

May5
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 14.75 M, Net Income -202.49 M, EPS -0.5027

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
SEVNR
0.0493
+77.34%
+0.021
FOXX
3.540
+75.16%
+1.519
PTN
22.820
+57.49%
+8.330
MNDR
4.750
+56.25%
+1.710
NVVE
0.2558
+55.88%
+0.092
DVLT
2.550
+46.55%
+0.810
CCTG
0.2364
+43.01%
+0.071
IVDA
0.8760
+34.67%
+0.226
BLMZ
1.000
+30.55%
+0.234
ALPS
1.180
+29.56%
+0.269
View More
Terms & Conditions
  • Terms of Service
  • Privacy Policy